A Two‐Stage Strategy to Reprogram Cyanine Photosensitizers as Controllable‐Pyroptosis Inducers for Anticancer Phototherapy
- 8 November 2026
- journal article
- Published by Wiley in Advanced Healthcare Materials
Abstract
Pyroptosis, a lytic and inflammatory form of programmed cell death, provides a promising strategy for antitumor immunotherapy. However, controllable modulation of pyroptosis using phototherapeutic agents remains challenging. In this study, we report a two‐stage molecular reprogramming method to rationally design cyanine photosensitizers with tunable pyroptosis‐inducing activity. We first reprogram IR808 into a novel photosensitizer T808, by integrating a tetraphenylethylene unit with IR808, which consequently enhances excited ‐ state features related to intersystem crossing (ISC) and reactive oxygen species (ROS) generation capability, accompanied by inducing pyroptosis under irradiation. In the second process, T808 is conjugated with poly(ethylene glycol) (PEG) chains of varying lengths (M.W. 550, 1000, and 2000 Da) to finely modulate the pyroptotic efficacy. The relationship of PEG chain length with pyroptosis‐inducing activity is in the order of PT550 > T808 > PT1000 >> PT2000. Cellular and in vivo studies show that T808, PT550, and PT1000 treatments suppress tumor growth and induce pyroptosis with occurrence of immunogenic cell death (ICD). Even under a lower intratumoral injection dose (25 µM), T808 and PT550 therapies exhibit remarkable antitumor efficacy with measurable pyroptosis features. This work provides a new insight into reprogramming cyanine photosensitizers into pyroptosis‐active molecules, and proposes possible structural association of PEGylated cyanines with the pyroptosis activity.Keywords
Funding Information
- National Natural Science Foundation of China (82473877)
- State Key Laboratory of Natural and Biomimetic Drugs (K202410)
This publication has 22 references indexed in Scilit:
- Engineered bacterial membrane biomimetic covalent organic framework as nano-immunopotentiator for cancer immunotherapyBioactive Materials, 2025
- Optimizing Photosensitizers with Type I and Type II ROS Generation Through Modulating Triplet Lifetime and Intersystem Crossing EfficiencyAdvanced Functional Materials, 2024
- A General Molecular Structural Design for Highly Efficient Photopyroptosis that can be Activated within 10 s IrradiationAdvanced Materials, 2024
- Pyroptosis‐Mediated Synergistic Photodynamic and Photothermal Immunotherapy Enabled by a Tumor‐Membrane‐Targeted Photosensitive DimerAdvanced Materials, 2023
- Immunomodulatory‐Photodynamic Nanostimulators for Invoking Pyroptosis to Augment Tumor ImmunotherapyAdvanced Healthcare Materials, 2022
- Software update: The ORCA program system—Version 5.0WIREs Computational Molecular Science, 2022
- Near infrared light triggered ternary synergistic cancer therapy via L-arginine-loaded nanovesicles with modification of PEGylated indocyanine greenActa Biomaterialia, 2022
- BODIPY‐Based Photodynamic Agents for Exclusively Generating Superoxide Radical over Singlet OxygenAngewandte Chemie International Edition, 2021
- PEGylation Regulates Self‐Assembled Small‐Molecule Dye–Based Probes from Single Molecule to Nanoparticle Size for Multifunctional NIR‐II BioimagingAdvanced Healthcare Materials, 2018
- Multiwfn: A multifunctional wavefunction analyzerJournal of Computational Chemistry, 2011